Related Experiment Videos
[Hepatotoxicity of moxisylyte chlorhydrate: a new case]
Gastroenterologie Clinique Et Biologique
|January 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4.
Journal of viral hepatitis·2012
Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features.
Alimentary pharmacology & therapeutics·2007
Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma.
Alimentary pharmacology & therapeutics·2003
[Treatment of chronic hepatitis B: adherence and safety].
Gastroenterologie clinique et biologique·2010
[Long-term therapy for chronic hepatitis B in HIV co-infected patients].
Gastroenterologie clinique et biologique·2010
[Analogs combination therapy in chronic hepatitis B: when and how?].
Gastroenterologie clinique et biologique·2010
[HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
Gastroenterologie clinique et biologique·2010
[HBsAg quantification: virological significance].
Gastroenterologie clinique et biologique·2010
[Influence of treatment on long-term evolution of chronic hepatitis B].
Gastroenterologie clinique et biologique·2010
Influenza mitigation recommendations, symptoms, and viral RNA shedding durations-2023-24 and 2024-25 seasons.
American journal of epidemiology·2026
Comparative adjuvant therapy to reduce vancomycin-associated nephrotoxicity in an animal model.
Antimicrobial agents and chemotherapy·2026
Urban soils along the Kern River and Los Gatos Creek are hotspots for Coccidioides in the San Joaquin Valley of California.
Applied and environmental microbiology·2026
When tests don't fit the rules: regulatory challenges for agnostic metagenomic next-generation sequencing in infectious diseases diagnostics.
Journal of clinical microbiology·2026
A bireporter recombinant SARS-CoV-2 Omicron BA.5 for in vitro and in vivo studies.
Microbiology spectrum·2026
The people behind the papers - Rashi Agarwal, Joergen Benjaminsen and Joachim Wittbrodt.
Development (Cambridge, England)·2026